Skip to main content

Table 1 Characteristics of ovarian cancer patients and control groups: benign ovarian tumor and healthy subjects

From: M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patients

Study group

 

Number of patients

Epithelial ovarian cancer patients

 

110 (100%)

 • Median age (range)

 

58 (46–80)

-sub-type serous epithelial

 

61 (55%)

 • Median age (range)

 

58 (46–81)

-sub-type endometrioid epithelial

 

49 (45%)

 • Median age (range)

 

59 (48–86)

Tumor stage

IA

6 (5.4%)

IB

8 (7.3%)

IC

14 (12.7%)

IIA

9 (8.2%)

IIB

10 (9.1%)

IIC

9 (8.2%)

IIIA

10 (9.1%)

IIIB

10 (9.1%)

IIIC

8 (7.3%)

IV (metastases)

26 (23.6%)

Menopausal status: - postmenopausal

 

110 (100%)

Benign ovarian tumor patients

 

70 (100%)

-type cystis serous

 

35 (50%)

-type cystis endometrioides

 

35 (50%)

Median age (range)

 

52 (48–68)

Menopausal status: - postmenopausal

 

70 (100%)

Healthy subjects

 

50 (100%)

Median age (range)

 

56 (48–66)

Menopausal status: - postmenopausal

 

50 (100%)